Reading Time: 6 minutes Last month we hosted our annual event for early career researchers (ECRs) in the UK. MND EnCouRage UK is a two day event which aims
Category: Markers of Disease Progression
MND EnCouRage UK: Supporting the future leaders of MND research
Reading Time: 7 minutes Increasing our understanding of MND, improving care and finding new potential treatments for the disease relies upon very talented and dedicated scientists working in MND
Reading Time: 6 minutes Please note that this blog talks about sensitive topics such as death and tissue donation throughout. Researchers use many different tools to increase our understanding
Developing a potential microRNA blood test for ALS diagnosis
Reading Time: 4 minutes I’m Hannah, a PhD student from the University of Nottingham, and a Communications Ambassador for the 34th International Symposium on ALS/MND that took place in
Reading Time: 5 minutes Hi, my name is Avril Mc Tague. I am undertaking a Ph.D. at Trinity College, Dublin, Ireland as part of the Multidisciplinary Innovation and Research Advancing Neurological care in a Digital Age (MIRANDA) doctoral award programme. This is funded by the Health Research Board in Ireland. I was one of five symposium communication ambassadors at last year’s international symposium.
Celebrating the contribution of Women to MND research
Reading Time: 7 minutes Each year the 11th of February sees the world recognise and celebrate the contributions of women in science. The International day of Women and Girls
Reuniting the MND community at the 34th International Symposium on ALS/MND
Reading Time: 4 minutes After 3 years of online events, the MND research and healthcare community reunited in-person at the 34th International Symposium on ALS/MND in Basel, Switzerland! From
Symposium Preview: Meet the ALS/FTD Plenary Speakers…Part 1
Reading Time: 5 minutes Every year, the team works hard to build on the previous year’s success. This year we are excited to include a series of three ALS-FTD joint sessions, in collaboration with the International Society for Frontotemporal Dementias, in the programme.
Some people with ALS, the most common form of MND, also develop a form of dementia known as frontotemporal dementia (FTD). FTD is a group of disorders where the nerve cells in two sets of lobes (frontal and temporal) in the brain are damaged. In a similar way to how motor neurones break down in MND and cause loss of function in muscles, the damage to the nerve cells in FTD causes the connections between parts of the brain to break down. As more cells become damaged and die this can lead to symptoms such as problems with memory, thinking or language, changes in mood, emotions and behaviour.
Symposium Preview: Meet the Symposium Communications Ambassadors
Reading Time: 7 minutes Each year at the Symposium, there is a huge amount of research presented on a range of topics from across the globe. With the Symposium returning to an in-person event this year, we are keen to increase the number of updates we share for those not able to attend, including people living with and affected by MND.
To help us do this, we have launched a new Symposium Communications Ambassador Programme so we can bring more of the research from the Symposium to non-scientific audiences. This programme was open for applications from early career researchers working in MND, who were interested in helping us shine a light on MND research happening across the world. This year we have 5 early career researchers taking part in the Programme, who will gain experience and new skills in communicating research to different audiences. Before, during and after the Symposium our Ambassador’s will be helping us to share the latest research with the MND community.